LA
KIDS icon

Lee Ainslie’s OrthoPediatrics KIDS Stock Holding History

Lee Ainslie’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,115
Closed -$73K – 488
2021
Q3 		$73K Buy
+1,115
New +$72.4K ﹤0.01% 607
2021
Q2 		– Sell
-1,338
Closed -$65K – 776
2021
Q1 		$65K Buy
+1,338
New +$64.2K ﹤0.01% 632

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lee Ainslie's KIDS Position: Q4 2021 in Review

Lee Ainslie sold out of OrthoPediatrics (KIDS) in Q4 2021, closing a stake of 1,115 shares — an estimated $73K sold.

Lee Ainslie first reported a position in KIDS in Q1 2021 and held it in 2 quarters. The position peaked at $73K in Q3 2021. 131 funds tracked by Wall St. Rank hold KIDS as of Q4 2021.

  • Lee Ainslie reported no remaining OrthoPediatrics position as of Q4 2021 after selling out during the quarter.
  • Lee Ainslie sold 1,115 OrthoPediatrics shares in Q4 2021, an estimated $73K.
  • Lee Ainslie first reported a position in OrthoPediatrics in Q1 2021 and held it in 2 quarters.
  • Lee Ainslie's OrthoPediatrics position peaked at $73K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.